|
Volumn 20, Issue 4, 1999, Pages 224-227
|
Cost-benefit analysis for hepatitis A vaccine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS A VACCINE;
HEPATITIS VACCINE;
VIRUS ANTIBODY;
ADOLESCENT;
ADULT;
AGE;
ARTICLE;
BLOOD;
CHILD;
CHINA;
COST BENEFIT ANALYSIS;
ECONOMICS;
FEMALE;
HEPATITIS A;
HEPATITIS A VIRUS;
HUMAN;
IMMUNOLOGY;
INFANT;
MALE;
MIDDLE AGED;
PRESCHOOL CHILD;
VACCINATION;
ADOLESCENT;
ADULT;
AGE FACTORS;
ANTIBODIES, VIRAL;
CHILD;
CHILD, PRESCHOOL;
CHINA;
COST-BENEFIT ANALYSIS;
FEMALE;
HEPATITIS A;
HEPATITIS A VACCINES;
HEPATOVIRUS;
HUMANS;
INFANT;
MALE;
MIDDLE AGED;
VACCINATION;
VIRAL HEPATITIS VACCINES;
|
EID: 0033169811
PISSN: 02546450
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|